SECURITIES AND EXCHANGE COMMISSION
 
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of
 
the Securities Exchange Act 1934
 
Date of Report (Date of earliest event reported):   June 17, 2011
 
NewCardio, Inc.
(Exact name of registrant as specified in charter)
 
Delaware
(State or other jurisdiction of incorporation)
 
Delaware
 
333-149166
 
20-1826789
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
     
 
2350 Mission College Blvd., Suite 1175, Santa Clara, CA
 
95054
(Address of Principal Executive Offices)
(Zip Code)
     
Registrant’s telephone number, including area code:
(408) 516-5000
 
N/A
(Former Name or Former Address, is Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:
 
[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
[  ]  Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))
 
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
 
 
 
 
Item 8.01.  Other Events
 
In connection with an ongoing review of its corporate governance practices, the board of directors (the “Board”) of NewCardio, Inc. (the “Company”) has determined to periodically rotate the position of Chairman of the Board.  On June 17, 2011, Dr. Patrick Maguire, a member of the Board, assumed the role of Chairman, a position that has been held since March 2008 by Dr. Mark Kroll.  Dr. Kroll will continue to serve as a member of the Board.

 
 
 
 
 
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
NEWCARDIO, INC.
 
       
Dated: June 20, 2011
By:
/s/ Richard D. Brounstein  
   
Name:  Richard D. Brounstein
 
   
Title:    Chief Financial Officer
 
       

 
 

 
 
 


Newcardio (CE) (USOTC:NWCI)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Newcardio (CE) Charts.
Newcardio (CE) (USOTC:NWCI)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Newcardio (CE) Charts.